Erwinia L-asparaginase

Erwinia L-asparaginase
Trade Name
Orphan Indication Acute lymphoblastic leukemia
USA Market Approval USA
USA Designation Date 1985-01-25 00:00:00
Sponsor Lyphomed, Inc.;;
Related Access Program
Novartis Pharmaceuticals – Acute Lymphoblastic Leukemia University of California, San Francisco – Acute Lymphoblastic Leukemia ERYtech Pharma – Acute Lymphoblastic Leukemia University of California, San Francisco – Acute lymphoblastic leukemia ERYtech Pharma – Acute lymphoblastic leukemia Amgen – Acute lymphoblastic leukemia